Steven Cohen Pardes Biosciences, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.4 - $1.95 $57 - $79	41 New	41 $0
Q2 2022 Aug 15, 2022	SELL	$2.84 - $8.57 $470,684 - $1.42 Million	-165,734 Reduced 38.35%	266,400 $818,000
Q1 2022 May 16, 2022	BUY	$5.64 - $15.64 $1.66 Million - $4.61 Million	294,900 Added 214.89%	432,134 $3.12 Million
Q4 2021 Feb 14, 2022	BUY	$9.8 - $17.02 $1.34 Million - $2.34 Million	137,234 New	137,234 $2.25 Million

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.